MedPath

Evaluation of GnRH long-acting agonist protocols and GnRH antagonist protocol in controlled ovarian stimulation in in vitro fertilization in infertile women with poor ovarian response

Phase 3
Recruiting
Conditions
Infertility.
Female infertility
Registration Number
IRCT20110509006420N28
Lead Sponsor
Yazd University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
170
Inclusion Criteria

IVF/ICSI candidates
Women who respond poorly to ovulation stimulation: ovarian reserve less than 1.2 ng/ml and AFC number less than 5 POSEIDON group 3-4
Women between the ages of 18 and 45

Exclusion Criteria

Asherman's history
Severe uterine adenomyosis
Egg donation cycles
Cases of severe male infertility (azoospermia)
Cases where surrogacy is used

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Clinical pregnancy. Timepoint: 4 weeks after embryo transfer. Method of measurement: sonography.
Secondary Outcome Measures
NameTimeMethod
The number of embryos with qualities of A,B,or C. Timepoint: En 1-2 days after ovarian puncture. Method of measurement: Microscopic manual counting by embryologist.;En The duration of controlled ovarian stimulation period. Timepoint: Immediatly after controlled ovarian stimulation. Method of measurement: Time scale(day).;The dosage of Gonadotropin used. Timepoint: After controlled ovarian stimulation. Method of measurement: Counting.;Chemical pregnancy. Timepoint: 2 weeks after embryo transfer. Method of measurement: pregnancy test.;Implantation. Timepoint: After a positive pregnancy test. Method of measurement: sonography.
© Copyright 2025. All Rights Reserved by MedPath